Skip to content
10-Q

Quarterly Report

Pear Therapeutics, Inc.

0001835567-22-000069

← back to feed
Filed
Aug 11, 2022 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2022 · Aug 8, 2022 138.77M sh
Shares Diluted Q2 2022 · Jun 30, 2022 147.42M sh
Shares Diluted Q2 2022 · Jun 30, 2022 138.07M sh
Shares Diluted Q2 2022 · Jun 30, 2021 111.95M sh
Shares Diluted Q2 2022 · Jun 30, 2021 110.31M sh
Capex Q2 2022 · Jun 30, 2022 $1.82M
Capex Q2 2022 · Jun 30, 2021 $1.5M
Operating Cash Flow Q2 2022 · Jun 30, 2022 −$66.35M
Operating Cash Flow restated Q2 2022 · Jun 30, 2021 −$43.87M
Long Term Debt Q2 2022 · Jun 30, 2022 $0
Short Term Debt Q2 2022 · Jun 30, 2022 $27.35M
Short Term Debt Q2 2022 · Dec 31, 2021 $26.99M
Short Term Investments Q2 2022 · Jun 30, 2022 $46.92M
Short Term Investments Q2 2022 · Dec 31, 2021 $5M
Cash And Equivalents Q2 2022 · Jun 30, 2022 $60.19M
Cash And Equivalents Q2 2022 · Dec 31, 2021 $169.57M
Stockholders Equity Q2 2022 · Jun 30, 2022 $79.04M
Stockholders Equity Q2 2022 · Mar 31, 2022 $69.51M
Stockholders Equity Q2 2022 · Dec 31, 2021 $90.43M
Stockholders Equity restated Q2 2022 · Jun 30, 2021 $58.2M
Stockholders Equity restated Q2 2022 · Mar 31, 2021 $85.56M
Stockholders Equity restated Q2 2022 · Dec 31, 2020 $87.12M
Current Liabilities Q2 2022 · Jun 30, 2022 $46.97M
Current Liabilities Q2 2022 · Dec 31, 2021 $47.17M
Total Liabilities Q2 2022 · Jun 30, 2022 $63.48M
Total Liabilities Q2 2022 · Dec 31, 2021 $106.73M
Current Assets Q2 2022 · Jun 30, 2022 $120.87M
Current Assets Q2 2022 · Dec 31, 2021 $185.24M
Total Assets Q2 2022 · Jun 30, 2022 $142.52M
Total Assets Q2 2022 · Dec 31, 2021 $197.16M
Eps Diluted Q2 2022 · Jun 30, 2022 $0.04
Eps Diluted Q2 2022 · Jun 30, 2022 −$0.13
Eps Diluted Q2 2022 · Jun 30, 2021 −$0.25
Eps Diluted Q2 2022 · Jun 30, 2021 −$0.48
Eps Basic Q2 2022 · Jun 30, 2022 $0.04
Eps Basic Q2 2022 · Jun 30, 2022 −$0.13
Eps Basic Q2 2022 · Jun 30, 2021 −$0.25
Eps Basic Q2 2022 · Jun 30, 2021 −$0.48
Sga Expense Q2 2022 · Jun 30, 2022 $21M
Sga Expense Q2 2022 · Jun 30, 2022 $43.75M
Sga Expense Q2 2022 · Jun 30, 2021 $14.55M
Sga Expense Q2 2022 · Jun 30, 2021 $27.85M
Rd Expense Q2 2022 · Jun 30, 2022 $12.72M
Rd Expense Q2 2022 · Jun 30, 2022 $25.98M
Rd Expense Q2 2022 · Jun 30, 2021 $7.88M
Rd Expense Q2 2022 · Jun 30, 2021 $15.37M
Net Income Q2 2022 · Jun 30, 2022 $5.46M
Net Income Q2 2022 · Jun 30, 2022 −$18.4M
Net Income Q2 2022 · Mar 31, 2022 −$23.86M
Net Income restated Q2 2022 · Jun 30, 2021 −$28.2M
Net Income restated Q2 2022 · Jun 30, 2021 −$52.59M
Net Income restated Q2 2022 · Mar 31, 2021 −$24.39M
Operating Income Q2 2022 · Jun 30, 2022 −$32.82M
Operating Income Q2 2022 · Jun 30, 2022 −$67.56M
Operating Income restated Q2 2022 · Jun 30, 2021 −$21.95M
Operating Income restated Q2 2022 · Jun 30, 2021 −$43.1M
Cost Of Revenue Q2 2022 · Jun 30, 2022 $2.4M
Cost Of Revenue Q2 2022 · Jun 30, 2022 $3.88M
Cost Of Revenue Q2 2022 · Jun 30, 2021 $727K
Cost Of Revenue Q2 2022 · Jun 30, 2021 $1.47M
Revenue Q2 2022 · Jun 30, 2022 $3.3M
Revenue Q2 2022 · Jun 30, 2022 $6.05M
Revenue Q2 2022 · Jun 30, 2021 $1.2M
Revenue Q2 2022 · Jun 30, 2021 $1.58M